Activation of mitogen-activated protein kinase pathways by the granulocyte colony-stimulating factor receptor: Mechanisms and functional consequences

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 591-607

  Kendrick, Tulene S ^a   Bogoyevitch, Marie A ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

c Jun; Epidermal growth factor; ERK 1 2; ERK5; Fibroblast growth factor; Function; GCSF receptor; Granulocyte colony stimulating factor; Kinase; MAPK pathways; MAPKKK; N terminal; Nerve growth factor; Neutrophil; Oncostatin; p38; Proliferation; Src homology

Indexed keywords

EID: 34249826967     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2085     Document Type: Article

References (204)

1. Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. H. Cobb, and G. D. Yancopoulos: ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675 (1991)
2. Kyriakis, J. M., J. R. Woodgett, and J. Avruch: The stress-activated protein kinases. A novel ERK subfamily responsive to cellular stress and inflammatory cytokines. Ann N Y Acad Sci 766, 303-319 (1995)
3. Bogoyevitch, M. A. and N. W. Court: Counting on mitogen-activated protein kinases-ERKs 3, 4, 5, 6, 7 and 8. Cell Signal 16, 1345-1354 (2004)
4. Roberts, A. W.: G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23, 33-41 (2005)
5. Burgess, A. W. and D. Metcalf: The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56, 947-958 (1980)
6. Burgess, A. W. and D. Metcalf: Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells. Int J Cancer 26, 647-654 (1980)
7. Lieschke, G. J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan, and A. R. Dunn: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746 (1994)
8. Lopez, A. F., N. A. Nicola, A. W. Burgess, D. Metcalf, F. L. Battye, W. A. Sewell, and M. Vadas: Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol 131, 2983-2988 (1983)
9. Colgan, S. P., P. W. Gasper, M. A. Thrall, T. C. Boone, A. M. Blancquaert, and W. J. Bruyninckx: Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor. Exp Hematol 20, 1229-1234 (1992)
10. Nicola, N. A. and D. Metcalf: Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines. Proc Natl Acad Sci USA 81, 3765-3769 (1984)
11. Demetri, G. D. and J. D. Griffin: Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791-2808 (1991)
12. Nicola, N. A. and D. Metcalf: Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J Cell Physiol 124, 313-321 (1985)
13. Fukunaga, R., E. Ishizaka-Ikeda, and S. Nagata: Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem 265, 14008-14015 (1990)
14. Nicola, N. A. and L. Peterson: Identification of distinct receptors for two hemopoietic growth factors (granulocyte colony-stimulating factor and multipotential colony-stimulating factor) by chemical cross-linking. J Biol Chem 261, 12384-12389 (1986)
15. Fukunaga, R., Y. Seto, S. Mizushima, and S. Nagata: Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc Natl Acad Sci U S A 87, 8702-8706 (1990)
16. Fukunaga, R., E. Ishizaka-Ikeda, Y. Seto, and S. Nagata: Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 61, 341-350 (1990)
17. Pan, C. X., R. Fukunaga, S. Yonehara, and S. Nagata: Unidirectional cross-phosphorylation between the granulocyte colony-stimulating factor and interleukin 3 receptors. J Biol Chem 268, 25818-25823 (1993)
18. Horan, T., J. Wen, L. Narhi, V. Parker, A. Garcia, T. Arakawa, and J. Philo: Dimerization of the extracellular domain of granuloycte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes. Biochemistry 35, 4886-4896 (1996)
19. Nicholson, S. E., A. C. Oates, A. G. Harpur, A. Ziemiecki, A. F. Wilks, and J. E. Layton: Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci USA 91, 2985-2988 (1994)
20. Yoshikawa, A., H. Murakami, and S. Nagata: Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor. EMBO J 14, 5288-5296 (1995)
21. Nicholson, S. E., U. Novak, S. F. Ziegler, and J. E. Layton: Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 86, 3698-3704 (1995)
22. Shimoda, K., J. Feng, H. Murakami, S. Nagata, D. Watling, N. C. Rogers, G. R. Stark, I. M. Kerr, and J. N. Ihle: Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 90, 597-604 (1997)
23. Matsuda, T., M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mano, H. Hirai, O. N. Witte, and T. Hirano: Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85, 627-633 (1995)
24. Corey, S. J., A. L. Burkhardt, J. B. Bolen, R. L. Geahlen, L. S. Tkatch, and D. J. Tweardy: Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci USA 91, 4683-4687 (1994)
25. Ward, A. C., J. L. Monkhouse, X. F. Csar, I. P. Touw, and P. A. Bello: The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor. Biochem Biophys Res Commun 251, 117-123 (1998)
26. Corey, S. J., P. M. Dombrosky-Ferlan, S. Zuo, E. Krohn, A. D. Donnenberg, P. Zorich, G. Romero, M. Takata, and T. Kurosaki: Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem 273, 3230-3235 1998)
27. Grishin, A., S. Sinha, V. Roginskaya, M. J. Boyer, J. Gomez-Cambronero, S. Zuo, T. Kurosaki, G. Romero, and S. J. Corey: Involvement of She and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Oncogene 19, 97-105 (2000)
28. Avalos, B. R., J. M. Parker, D. A. Ware, M. G. Hunter, K. A. Sibert, and B. J. Druker: Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils. Exp Hematol 25, 160-168 (1997)
29. Miyazato, A., Y. Yamashita, K. Hatake, Y. Miura, K. Ozawa, and H. Mano: Tec protein tyrosine kinase is involved in the signaling mechanism of granulocyte colony-stimulating factor receptor. Cell Growth Differ 7, 1135-1139 (1996)
30. Dong, F., J. S. Gutkind, and A. C. Larner: Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. J Biol Chem 276, 10811-10816 (2001)
31. Rausch, O. and C. J. Marshall: Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. J Biol Chem 274, 4096-4105 (1999)
32. Rausch, O. and C. J. Marshall: Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol 17, 1170-1179 (1997)
33. Dong, F. and A. C. Larner: Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 95, 1656-1662 (2000)
34. Chakraborty, A., S. M. White, T. S. Schaefer, E. D. Ball, K. F. Dyer, and D. J. Tweardy: Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood' 88, 2442-2449 (1996)
35. Chakraborty, A., K. F. Dyer, M. Cascio, T. A. Mietzner, and D. J. Tweardy: Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood 93, 15-24 (1999)
36. Hunter, M. G. and B. R. Avalos: Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 95, 2132-2137 (2000)
37. Garrington, T. P. and G. L. Johnson: Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11, 211-218 (1999)
38. Davis, R. J.: Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 64, 1-12 (1999)
39. Strniskova, M., M. Barancik, and T. Ravingerova: Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen Physiol Biophys 21, 231-255 (2002)
40. Davis, R. J.: Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 (2000)
41. Johnson, G. L. and R. Lapadat: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912 (2002)
42. Whitehurst, C. E., T. G. Boulton, M. H. Cobb, and T. D. Geppert: Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 beta-phorbol 12-myristate 13-acetate-induced phosphorylation and activation. J Immunol 148, 3230-3237 (1992)
43. Leevers, S. J. and C. J. Marshall: Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J 11, 569-574 (1992)
44. Fairhurst, R. M., M. Daeipour, M. C. Amaral, and A. E. Nel: Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutin in blasts by recombinant interleukin-2: contrasting features with CD3 activation. Immunology 79, 112-118 (1993)
45. Casillas, A. M., K. Amaral, S. Chegini-Farahani, and A. E. Nel: Okadaic acid activates p42 mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: contrast with phorbol 12-myristate 13-acetate. Biochem J 290 (Pt 2), 545-550 (1993)
46. Loeb, D. M., H. Tsao, M. H. Cobb, and L. A. Greene: NGF and other growth factors induce an association between ERK1 and the NGF receptor, gp140prototrk. Neuron 9, 1053-1065 (1992)
47. Troppmair, J., J. T. Bruder, H. Munoz, P. A. Lloyd, J. Kyriakis, P. Banerjee, J. Avruch, and U. R. Rapp: Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 269, 7030-7035 (1994)
48. Chiri, S., S. Bogliolo, J. Ehrenfeld, and B. Ciapa: Activation of extracellular signal-regulated kinase ERK after hypo-osmotic stress in renal epithelial A6 cells. Biochim Biophys Acta 1664, 224-229 (2004)
49. Schliess, F., R. Schreiber, and D. Haussinger: Activation of extracellular signal-regulated kinases Erk-1 and Erk-2 by cell swelling in H4IIE hepatoma cells. Biochem J 309 (Pt 1), 13-17 (1995)
50. Yang, X. Y., Z. Zhang, and D. M. Cohen: ERK activation by urea in the renal inner medullary mIMCD3 cell line. Am J Physiol 277, F176-F185 (1999)
51. Schmid-Alliana, A., L. Menou, S. Manie, H. Schmid-Antomarchi, M. A. Millet, S. Giuriato, B. Ferrua, and B. Rossi: Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production. J Biol Chem 273, 3394-3400 (1998)
52. Tarr, P. E., R. Roncarati, G. Pelicci, P. G. Pelicci, and L. D'Adamio: Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with She. J Biol Chem 211, 16798-16804 (2002)
53. Sasaoka, T., M. Ishiki, T. Wada, H. Hori, H. Hirai, T. Haruta, H. Ishihara, and M. Kobayashi: Tyrosine phosphorylation-dependent and -independent role of She in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Endocrinology 142, 5226-5235 (2001)
54. Dunican, D. J., E. J. Williams, F. V. Howell, and P. Doherty: Selective inhibition of fibroblast growth factor (FGF)-stimulated mitogenesis by a FGF receptor-1-derived phosphopeptide. Cell Growth Differ 12, 255-264 (2001)
55. Hermanns, H. M., S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann: Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein She is specifically recruited to rhe oncostatin M receptor. J Biol Chem 275, 40742-40748 (2000)
56. Sakaguchi, K., Y. Okabayashi, Y. Kido, S. Kimura, Y. Matsumura, K. Inushima, and M. Kasuga: Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells. Mol Endocrinol 12, 536-543 (1998)
57. van der Geer, P., S. Wiley, V. K. Lai, J. P. Olivier, G. D. Gish, R. Stephens, D. Kaplan, S. Shoelson, and T. Pawson: A conserved amino-terminal She domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr Biol 5, 404-412 (1995)
58. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger: The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70, 431-442 (1992)
59. Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg: Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363, 45-51 (1993)
60. Boriack-Sjodin, P. A., S. M. Margarit, D. Bar-Sagi, and J. Kuriyan: The structural basis of the activation of Ras by Sos. Nature 394, 337-343 (1998)
61. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch: Raf-1 activates MAP kinase-kinase. Nature 358, 417-421 (1992)
62. Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis: Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267, 682-685 (1995)
63. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw: ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivarion. EMBO J 14, 951-962 (1995)
64. Frodin, M. and S. Gammeltoft: Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151, 65-77 (1999)
65. Khokhlatchev, A. V., B. Canagarajah, J. Wilsbacher, M. Robinson, M. Atkinson, E. Goldsmith, and M. H. Cobb: Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605-615 (1998)
66. Pearson, G., F. Robinson, G. T. Beers, B. E. Xu, M. Karandikar, K. Berman, and M. H. Cobb: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22, 153-183 (2001)
67. Platanias, L. C.: Map kinase signaling pathways and hematologic malignancies. Blood 101, 4667-4679 (2003)
68. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852 (1994)
69. Smith, M. R., G. Heidecker, U. R. Rapp, and H. F. Kung: Induction of transformation and DNA synthesis after microinjection of raf proteins. Mol Cell Biol 10, 3828-3833 (1990)
70. Bos, J. L.: Ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689 (1989)
71. Hamad, N. M., J. H. Elconin, A. E. Karnoub, W. Bai, J. N. Rich, R. T. Abraham, C. J. Der, and C. M. Counter: Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 16, 2045-2057 (2002)
72. Oka, H., Y. Chatani, R. Hoshino, O. Ogawa, Y. Kakehi, T. Terachi, Y. Okada, M. Kawaichi, M. Kohno, and O. Yoshida: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 55, 4182-4187 (1995)
73. Sivaraman, V. S., H. Wang, G. J. Nuovo, and C. C. Malbon: Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99, 1478-1483 (1997)
74. Hoshino, R., Y. Chatani, T. Yamori, T. Tsuruo, H. Oka, O. Yoshida, Y. Shimada, Ari-i S, H. Wada, J. Fujimoto, and M. Kohno: Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogens 18, 813-822 (1999)
75. Davies, H., G. R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M. J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Ewing, Y. Floyd, K. Gray, S. Hall, R. Hawes, J. Hughes, V. Kosmidou, A. Menzies, C. Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, R. Wilson, H. Jayatilake, B. A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. J. Riggins, D. D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, J. W. Ho, S. Y. Leung, S. T. Yuen, B. L. Weber, H. F. Seigler, T. L. Darrow, H. Paterson, R. Marais, C. J. Marshall, R. Wooster, M. R. Stratton, and P. A. Futreal: Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002)
76. Towatari, M., H. Iida, M. Tanimoto, H. Iwata, M. Hamaguchi, and H. Saito: Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 11, 479-484 (1997)
77. Kim, S. C., J. S. Hahn, Y. H. Min, N. C. Yoo, Y. W. Ko, and W. J. Lee: Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 93, 3893-3899 (1999)
78. Pages, G., S. Guerin, D. Grail, F. Bonino, A. Smith, F. Anjuere, P. Auberger, and J. Pouyssegur: Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374-1377 (1999)
79. Hatano, N., Y. Mon, M. Oh-hora, A. Kosugi, T. Fujikawa, N. Nakai, H. Niwa, J. Miyazaki, T. Hamaoka, and M. Ogata: Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8, 847-856 (2003)
80. Yao, Y., W. Li, J. Wu, U. A. Germann, M. S. Su, K. Kuida, and D. M. Boucher: Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci U S A 100, 12759-12764 (2003)
81. Saba-El-Leil, M. K., F. D. Vella, B. Vernay, L. Voisin, L. Chen, N. Labrecque, S. L. Ang, and S. Meloche: An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4, 964-968 (2003)
82. Bashey, A., L. Healy, and C. J. Marshall: Proliferative but not nonproliferative responses to granulocyte colony-stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood 83, 949-957 (1994)
83. Akbarzadeh, S., A. C. Ward, D. O. McPhee, W. S. Alexander, G. J. Lieschke, and J. E. Layton: Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells. Blood 99, 879-887 (2002)
84. Hermans, M. H., G. J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward, and I. P. Touw: Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 101, 2584-2590 (2003)
85. Baumann, M., T. Frye, T. Naqvi, and J. Gomez-Cambronero: Normal neutrophil maturation is associated with selective loss of MAP kinase activation by G-CSF. Leuk Res 29, 73-78 (2005)
86. Koay, D. C., T. Nguyen, and A. C. Sartorelli: Distinct region of the granulocyte colony-stimulating factor receptor mediates proliferative signaling through activation of Janus kinase 2 and p44/42 mitogen-activated protein kinase. Cell Signal 14, 239-247 (2002)
87. Baumann, M. A., C. C. Paul, S. Lemley-Gillespie, M. Oyster, and J. Gomez-Cambronero: Modulation of MEK activity during G-CSF signaling alters proliferative versus differentiative balancing. Am J Hematol 68, 99-105 (2001)
88. Palacios, R. and M. Steinmetz: Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727-734 (1985)
89. Metcalf, D., T. Willson, M. Rossner, and P. Lock: Receptor insertion into factor-dependent murine cell lines to develop specific bioassays for murine G-CSF and M-CSF and human GM-CSF. Growth Factors 11, 145-152 (1994)
90. Rodriguez-Tarduchy, G., M. Collins, and A. Lopez-Rivas: Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 9, 2997-3002 (1990)
91. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270, 27489-27494 (1995)
92. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92, 7686-7689 (1995)
93. Kitagawa, S., F. Takaku, and S. Sakamoto: A comparison of the superoxide-releasing response in human polymorphonuclear leukocytes and monocytes. J Immunol 125, 359-364 (1980)
94. Kutsuna, H., K. Suzuki, N. Kamata, T. Kato, F. Kato, K. Mizuno, H. Kobayashi, M. Ishii, and S. Kitagawa: Actin reorganization and morphological changes in human neutrophils stimulated by TNF, GM-CSF, and G-CSF: the role of MAP kinases. Am J Physiol Cell Physiol 286, C55-C64 (2004)
95. Suzuki, K., M. Hino, F. Hato, N. Tatsumi, and S. Kitagawa: Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood 93, 341-349 (1999)
96. Suzuki, K., T. Hasegawa, C. Sakamoto, Y. M. Zhou, F. Hato, M. Hino, N. Tatsumi, and S. Kitagawa: Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: role in decreased responsiveness to inflammatory cytokines. J Immunol 166, 1185-1192 (2001)
97. Suzuki, K., M. Hino, H. Kutsuna, F. Hato, C. Sakamoto, T. Takahashi, N. Tatsumi, and S. Kitagawa: Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1 beta. J Immunol 167, 5940-5947 (2001)
98. Miranda, M. B., T. F. McGuire, and D. E. Johnson: Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16, 683-692 (2002)
99. Kyriakis, J. M. and J. Avruch: pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J Biol Chem 265, 17355-17363 (1990)
100. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7, 2135-2148 (1993)
101. Gupta, S., T. Barrett, A. J. Whitmarsh, J. Cavanagh, H. K. Sluss, B. Derijard, and R. J. Davis: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15, 2760-2770 (1996)
102. Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037 (1994)
103. Kallunki, T., B. Su, I. Tsigelny, H. K. Sluss, B. Derijard, G. Moore, R. Davis, and M. Karin: JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8, 2996-3007 (1994)
104. Yang, D. D., C. Y. Kuan, A. J. Whitmarsh, M. Rincon, T. S. Zheng, R. J. Davis, P. Rakic, and R. A. Flavell: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870 (1997)
105. Cano, E., C. A. Hazzalin, and L. C. Mahadevan: Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol 14, 7352-7362 (1994)
106. Kyriakis, J. M. and J. Avruch: Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18, 567-577 (1996)
107. Sluss, H. K., T. Barrett, B. Derijard, and R. J. Davis: Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 14, 8376-8384 (1994)
108. Terada, K., Y. Kaziro, and T. Satoh: Ras-dependent activation of c-Jun N-terminal kinase/stress-activated protein kinase in response to interleukin-3 stimulation in hematopoietic BaF3 cells. J Biol Chem 272, 4544-4548 (1997)
109. Foltz, I. N. and J. W. Schrader: Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89, 3092-3096 (1997)
110. Crawley, J. B., L. Rawlinson, F. V. Lali, T. H. Page, J. Saklatvala, and B. M. Foxwell: T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem 272, 15023-15027 (1997)
111. Nagata, Y., E. Nishida, and K. Todokoro: Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89, 2664-2669 (1997)
112. Nihalani, D., D. Meyer, S. Pajni, and L. B. Holzman: Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components. EMBO J 20, 3447-3458 (2001)
113. Kim, I. J., K. W. Lee, B. Y. Park, J. K. Lee, J. Park, I. Y. Choi, S. J. Eom, T. S. Chang, M. J. Kim, Y. I. Yeom, S. K. Chang, Y. D. Lee, E. J. Choi, and P. L. Han: Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brain. J Neurochem 72, 1335-1343 (1999)
114. Chen, W., M. A. White, and M. H. Cobb: Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway. J Biol Chem 277, 49105-49110 (2002)
115. Pomerance, M., M. C. Multon, F. Parker, C. Venot, J. P. Blondeau, B. Tocque, and F. Schweighoffer: Grb2 interaction with MEK-kinase 1 is involved in regulation of Jun-kinase activities in response to epidermal growth factor. JBiol Chem 273, 24301-24304 (1998)
116. Hashimoto, A., M. Kurosaki, N. Gotoh, M. Shibuya, and T. Kurosaki: She regulates epidermal growth factor-induced activation of the JNK signaling pathway. J Biol Chem 274, 20139-20143 (1999)
117. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81, 1147-1157 (1995)
118. Kiefer, F., L. A. Tibbies, M. Anafi, A. Janssen, B. W. Zanke, N. Lassam, T. Pawson, J. R. Woodgett, and N. N. Iscove: HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway. EMBO J15, 7013-7025 (1996)
119. Pombo, C. M., J. H. Kehrl, I. Sanchez, P. Katz, J. Avruch, L. I. Zon, J. R. Woodgett, T. Force, and J. M. Kyriakis: Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature 377, 750-754 (1995)
120. Whitmarsh, A. J. and R. J. Davis: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74, 589- 607 (1996)
121. Fleming, Y., C. G. Armstrong, N. Morrice, A. Paterson, M. Goedert, and P. Cohen: Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J 352 Pt 1, 145-154 (2000)
122. Wada, T., K. Nakagawa, T. Watanabe, G. Nishitai, J. Seo, H. Kishimoto, D. Kitagawa, T. Sasaki, J. M. Penninger, H. Nishina, and T. Katada: Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4: different contribution of SEK2/MKK7 isoforms to the synergistic activation. J Bio! Chem 276, 30892-30897 (2001)
123. Kyriakis, J. M. and J. Avruch: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-869 (2001)
124. Yang, D., C. Tournier, M. Wysk, H. T. Lu, J. Xu, R. J. Davis, and R. A. Flavell: Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc Natl Acad Sci USA 94, 3004-3009 (1997)
125. Tournier, C., C. Dong, T. K. Turner, S. N. Jones, R. A. Flavell, and R. J. Davis: MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15, 1419-1426 (2001)
126. Minden, A. and M. Karin: The JNK family of MAP kinases: regulation and function. Hormones and Signalling 1, 209-233 (1998)
127. Ip, Y. T. and R. J. Davis: Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10, 205-219 (1998)
128. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett: Phosphorylation of c-jun mediated by MAP kinases. Nature 353, 670-674 (1991)
129. Lei, K. and R. J. Davis: JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100, 2432-2437 (2003)
130. Gao, M., T. Labuda, Y. Xia, E. Gallagher, D. Fang, Y. C. Liu, and M. Karin: Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306, 271-275 (2004)
131. Sunayama, J., F. Tsuruta, N. Masuyama, and Y. Gotoh: JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170, 295-304 (2005)
132. Dunn, C., C. Wiltshire, A. MacLaren, and D. A. Gillespie: Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal 14, 585-593 (2002)
133. Leppa, S. and D. Bohmann: Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18, 6158-6162 (1999)
134. Nagata, Y., N. Takahashi, R. J. Davis, and K. Todokoro: Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92, 1859-1869 (1998)
135. Raitano, A. B., J. R. Halpern, T. M. Hambuch, and C. L. Sawyers: The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci USA 92, 11746-11750 (1995)
136. Hess, P., G. Pihan, C. L. Sawyers, R. A. Flavell, and R. J. Davis: Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet 32, 201-205 (2002)
137. Xu, X., O. Heidenreich, I. Kitajima, K. McGuire, Q. Li, B. Su, and M. Nerenberg: Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene 13, 135-142 (1996)
138. Krause, D., A. Lyons, C. Fennelly, and R. O'Connor: Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol. J Biol Chem 276, 19244-19252 (2001)
139. Nishina, H., K. D. Fischer, L. Radvanyi, A. Shahinian, R. Hakem, E. A. Rubie, A. Bernstein, T. W. Mak, J. R. Woodgett, and J. M. Penninger: Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385, 350-353 (1997)
140. Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, P. Ohashi, M. Rothe, D. V. Goeddel, and T. W. Mak: Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725 (1997)
141. Rajnavolgyi, E., N. Benbernou, B. Rethi, D. Reynolds, H. A. Young, M. Magocsi, K. Muegge, and S. K. Durum: IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases. Cell Signal 14, 761-769 (2002)
142. Chen, Y. R., X. Wang, D. Templeton, R. J. Davis, and T. H. Tan: The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271, 31929-31936 (1996)
143. Ichijo, H., E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94 (1997)
144. Saitoh, M., H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17, 2596-2606 (1998)
145. Hatai, T., A. Matsuzawa, S. Inoshita, Y. Mochida, T. Kuroda, K. Sakamaki, K. Kuida, S. Yonehara, H. Ichijo, and K. Takeda: Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria- dependent caspase activation. J Biol Chem 275, 26576-26581 (2000)
146. Dong, C., D. D. Yang, M. Wysk, A. J. Whitmarsh, R. J. Davis, and R. A. Flavell: Defective T cell differentiation in the absence of Jnk1. Science 282, 2092-2095 (1998)
147. Dong, C., D. D. Yang, C. Tournier, A. J. Whitmarsh, J. Xu, R. J. Davis, and R. A. Flavell: JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94 (2000)
148. Kuan, C. Y., D. D. Yang, D. R. Samanta Roy, R. J. Davis, P. Rakic, and R. A. Flavell: The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676 (1999)
149. Kendrick, T. S., R. J. Lipscombe, O. Rausch, S. E. Nicholson, J. E.
150. Ren, R., B. J. Mayer, P. Cicchetti, and D. Baltimore: Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161 (1993)
151. Maeno, K., K. Sada, S. Kyo, S. M. Miah, K. Kawauchi-Kamata, X. Qu, Y. Shi, and H. Yamamura: Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase. J Biol Chem 278, 24912-24920 (2003)
152. Foucault, I., Y. C. Liu, A. Bernard, and M. Deckert: The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function. J Biol Chem 278, 7146-7153 (2003)
153. Jevremovic, D., D. D. Billadeau, R. A. Schoon, C. J. Dick, and P. J. Leibson: Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. J Immunol 166, 7219-7228 (2001)
154. Barr, R. K., T. S. Kendrick, and M. A. Bogoyevitch: Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 277, 10987-10997 (2002)
155. Shklyaev, S. S., H. Namba, N. Mitsutake, G. Alipov, Y. Nagayama, S. Maeda, A. Ohtsuru, H. Tsubouchi, and S. Yamashita: Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes. Thyroid 11, 629-636 (2001)
156. Bain, J., H. McLauchlan, M. Elliott, and P. Cohen: The specificities of protein kinase inhibitors: an update. Biochem J 371, 199-204 (2003)
157. Fabian, M. A., W. H. Biggs, III, D. K. Treiber, C. E. Atteridge, M. D. Azimioara, M. G. Benedetti, T. A. Carter, P. Ciceri, P. T. Edeen, M. Floyd, J. M. Ford, M. Galvin, J. L. Gerlach, R. M. Grotzfeld, S. Herrgard, D. E. Insko, M. A. Insko, A. G. Lai, J. M. Lelias, S. A. Mehta, Z. V. Milanov, A. M. Velasco, L. M. Wodicka, H. K. Patel, P. P. Zarrinkar, and D. J. Lockhart: A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23, 329-336 (2005)
158. Gaillard, P., I. Jeanclaude-Etter, V. Ardissone, S. Arkinstall, Y. Cambet, M. Camps, C. Chabert, D. Church, R. Cirillo, D. Gretener, S. Halazy, A. Nichols, C. Szyndralewiez, P. A. Vitte, and J. P. Gotteland: Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase. J Med Chem 48, 4596-4607 (2005)
159. Carboni, S., A. Hiver, C. Szyndralewiez, P. Gaillard, J. P. Gotteland, and P. A. Vitte: AS601245 (1,3- benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J Pharmacol Exp Ther 310, 25-32 (2004)
160. Han, J., J. D. Lee, P. S. Tobias, and R. J. Ulevitch: Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268, 25009-25014 (1993)
161. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811 (1994)
162. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270, 7420-7426 (1995)
163. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027-1037 (1994)
164. Foltz, I. N., J. C. Lee, P. R. Young, and J. W. Schrader: Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 272, 3296-3301 (1997)
165. Gallo, K. A. and G. L. Johnson: Mixed-lineage kinase control of JNK and p38 pathways. Nat Rev Mol Cell Biol 3, 663-672 (2002)
166. Han, J., J. D. Lee, Y. Jiang, Z. Li, L. Feng, and R. J. Ulevitch: Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271, 2886-2891 (1996)
167. Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis: Mol Cell Biol 16, 1247-1255 (1996)
168. Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein, and A. R. Nebreda: Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6, 109-116 (2000)
169. Mudgett, J. S., J. Ding, L. Guh-Siesel, N. A. Chartrain, L. Yang, S. Gopal, and M. M. Shen: Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97, 10454-10459 (2000)
170. Tamura, K., T. Sudo, U. Senftleben, A. M. Dadak, R. Johnson, and M. Karin: Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102, 221-231 (2000)
171. Zarubin, T. and J. Han: Activation and signaling of the p38 MAP kinase pathway. Cell Res 15, 11-18 (2005)
172. Ono, K. and J. Han: The p38 signal transduction pathway: activation and function. Cell Signal 12, 1-13 (2000)
173. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, and J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams & P. R. Young: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746 (1994)
174. Baldassare, J. J., Y. Bi, and C. J. Bellone: The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J Immunol 162, 5367-5373 (1999)
175. Dinarello, C. A.: Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol 3, 941-948 (1991)
176. Martin, M. and K. Resch: Interleukin 1: more than a mediator between leukocytes. Trends Pharmacol Sci 9, 171-177 (1988)
177. Wilson, K. P., M. J. Fitzgibbon, P. R. Caron, J. P. Griffith, W. Chen, P. G. McCaffrey, S. P. Chambers, and M. S. Su: Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem 271, 27696-27700 (1996)
178. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364, 229-233 (1995)
179. Lee, J. C., D. E. Griswold, B. Votta, and N. Hanna: Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int J Immunopharmacol 10, 835-843 (1988)
180. Badger, A. M., J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold: Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279, 1453-1461 (1996)
181. Wadsworth, S. A., D. E. Cavender, S. A. Beers, P. Lalan, P. H. Schafer, E. A. Malloy, W. Wu, B. Fahmy, G. C. Olini, J. E. Davis, J. L. Pellegrino-Gensey, M. P. Wachter, and J. J. Siekierka: RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. J Pharmacol Exp Ther 291, 680-687 (1999)
182. Zijlstra, J. G., J. E. Tulleken, J. J. Ligtenberg, P. de Boer, and T. S. van der Werf: p38-MAPK inhibition and endotoxin induced tubular dysfunction in men. J Endotoxin Res 10, 402-405 (2004)
183. Kuma, Y., G. Sabio, J. Bain, N. Shpiro, R. Marquez, and A. Cuenda: BIRB796 inhibits all p38 isoforms in vitro and in vivo. J Biol Chem 280, 19472- 19479 (2005)
184. Pargellis, C., L. Tong, L. Churchill, P. F. Cirillo, T. Gilmore, A. G. Graham, P. M. Grob, E. R. Hickey, N. Moss, S. Pav, and J. Regan: Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol 9, 268-272 (2002)
185. Branger, J., B. van den Blink, S. Weijer, J. Madwed, C. L. Bos, A. Gupta, C. L. Yong, S. H. Polmar, D. P. Olszyna, C. E. Hack, S. J. van Deventer, M. P. Peppelenbosch, and P. T. van der: Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J Immunol 168, 4070-4077 (2002)
186. Branger, J., B. van den Blink, S. Weijer, A. Gupta, S. J. van Deventer, C. E. Hack, M. P. Peppelenbosch, and P. T. van der: Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Blood 101, 4446-4448 (2003)
187. van den Blink, B., J. Branger, S. Weijer, A. Gupta, S. J. van Deventer, M. P. Peppelenbosch, and P. T. van der: P38 mitogen activated protein kinase is involved in the downregulation of granulocyte CXC chemokine receptors 1 and 2 during human endotoxemia. J Clin Immunol 24, 37-41 (2004)
188. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105 (2000)
189. Srinivasa, S. P. and P. D. Doshi: Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line. Leukemia 16, 244-253 (2002)
190. Bussolino, F., J. M. Wang, P. Defilippi, F. Turrini, F. Sanavio, C. J. Edgell, M. Aglietta, P. Arese, and A. Mantovani: Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337, 471-473 (1989)
191. Fuste, B., G. Escolar, P. Marin, R. Mazzara, A. Ordinas, and M. Diaz-Ricart: G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditions. Exp Hematol 32, 765-772 (2004)
192. Fuste, B., R. Mazzara, G. Escolar, A. Merino, A. Ordinas, and M. Diaz-Ricart: Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38. Haematologica 89, 578-585 (2004)
193. Lee, J. D., R. J. Ulevitch, and J. Han: Primary structure of BMK1: a new mammalian map kinase. Biochem Biophys Res Commun 213, 715-724 (1995)
194. Zhou, G., Z. Q. Bao, and J. E. Dixon: Components of a new human protein kinase signal transduction pathway. J Biol Chem 270, 12665-12669 (1995)
195. Kamakura, S., T. Moriguchi, and E. Nishida: Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274, 26563-26571 (1999)
196. Kato, Y., R. I. Tapping, S. Huang, M. H. Watson, R. J. Ulevitch, and J. D. Lee: Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395, 713-716 (1998)
197. Chao, T. H., M. Hayashi, R. I. Tapping, Y. Kato, and J. D. Lee: MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J Biol Chem 274, 36035-36038 (1999)
198. Marinissen, M. J., M. Chiariello, M. Pallante, and J. S. Gutkind: A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol Cell Biol 19, 4289-4301 (1999)
199. Abe, J., M. Takahashi, M. Ishida, J. D. Lee, and B. C. Berk: c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J Biol Chem 272, 20389-20394 (1997)
200. Kato, Y., T. H. Chao, M. Hayashi, R. I. Tapping, and J. D. Lee: Role of BMK1 in regulation of growth factor-induced cellular responses. Immunol Res 21, 233-237 (2000)
201. Yan, L., J. Carr, P. R. Ashby, V. Murry-Tait, C. Thompson, and J. S. Arthur: Knockout of ERK5 causes multiple defects in placental and embryonic development. BMC Dev Biol 3,11 (2003)
202. Sohn, S. J., B. K. Sarvis, D. Cado, and A. Winoto: ERK5 regulates embryonic angiogenesis and acts as a hypoxia-sensitive represser of vascular endothelial growth factor expression. J Biol Chem 111, 43344-43351 (2002)
203. Regan, C. P., W. Li, D. M. Boucher, S. Spatz, M. S. Su, and K. Kuida: Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl Acad Sci U S A 99, 9248-9253 (2002)
204. Hii, C. S., D. S. Anson, M. Costabile, V. Mukaro, K. Dunning, and A. Ferrante: Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J Biol Chem 279, 49825-49834 (2004)